Clindamycin Phosphate Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Jun 1, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0009-4073-04
Dosage Form
Injection
Presentation
Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)
Initial Posting
Jun 1, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.